Skip to main content
SpringerLink
Log in

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder

  • Letter to the Editor
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Padilha SCOS., Virtuoso S, Tonin FS, Borba HHL, Pontarolo R (2018). Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis. Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-018-1125-0

    Article  PubMed  Google Scholar 

  2. Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M et al (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009885.pub2 (Art. No.: CD009885)

    Article  PubMed  Google Scholar 

  3. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y et al (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 391(10128):1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7

    Article  CAS  Google Scholar 

  4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12. https://doi.org/10.1016/0197-2456(95)00134-4

    Article  CAS  PubMed  Google Scholar 

  5. Higgins JPT, Altman DG, Sterne JAC (eds) (2017) Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (eds) Cochrane handbook for systematic reviews of interventions version 5.2.0 [updated June 2017]. Cochrane. http://www.training.cochrane.org/handbook

  6. Rodrigues-Tartari R, Swardfager W, Salum GA, Rohde LA, Cogo-Moreira H (2018) Assessing risk of bias in randomized controlled trials of methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Int J Methods Psychiatr Res 27:e1586. https://doi.org/10.1002/mpr.1586

    Article  Google Scholar 

  7. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L (2017) Industry sponsorship and research outcome. Cochrane Database of Syst Rev. https://doi.org/10.1002/14651858.MR000033.pub3 (Art. No.: MR000033)

    Article  Google Scholar 

  8. Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J et al (2016) Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009996.pub2 (Art. No.: CD009996)

    Article  PubMed  Google Scholar 

  9. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926. https://doi.org/10.1136/bmj.39489.470347.AD

    Article  PubMed  PubMed Central  Google Scholar 

  10. Catalá-López F, Hutton B, Núñez-Beltrán A, Page MJ, Ridao M, Macías Saint-Gerons D et al (2017) The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One 12:e0180355. https://doi.org/10.1186/s13643-015-0005-7

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cipriani A, Higgins JPT, Geddes JR, Salanti G (2013) Conceptual and technical challenges in network meta-analysis. Ann Intern Med 159:130–137. https://doi.org/10.7326/0003-4819-159-2-201307160-00008

    Article  PubMed  Google Scholar 

  12. InHout J, Ioannidis JPA, Rovers MM, Goerman JJ (2016) Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6:e010247. https://doi.org/10.1136/bmjopen-2015-010247

    Article  Google Scholar 

  13. Faltinsen EG, Storebø O, Jakobsen J, Boesen K, Lange T, Gluud C (2018) Network meta-analysis: the highest level of medical evidence? BMJ Evid Based Med 23:56–59. https://doi.org/10.1136/bmjebm-2017-110887

    Article  PubMed  Google Scholar 

  14. Del Re AC, Spielmans GI, Flückiger C, Wampold BE (2013) Efficacy of new generation antidepressants: differences seem illusory. PLoS One 8:e63509. https://doi.org/10.1371/journal.pone.0063509

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatric Research Unit, Region Zealand Psychiatry, Slagelse, Denmark

    Erlend Glasø Faltinsen & Ole Jakob Storebø

  2. Department of Psychology, University of Southern Denmark, Odense, Denmark

    Ole Jakob Storebø

  3. The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    Christian Gluud

Authors
  1. Erlend Glasø Faltinsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ole Jakob Storebø
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Gluud
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erlend Glasø Faltinsen.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standards

The manuscript does not contain clinical studies or patient data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faltinsen, E.G., Storebø, O.J. & Gluud, C. Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 28, 145–146 (2019). https://doi.org/10.1007/s00787-018-1164-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-018-1164-6

Search

Navigation